P: participants |
The general population (at least one country). |
Studies specifically on specific subgroups (e.g., healthcare professionals or people with a certain disease, such as diabetes or asthma) were excluded. |
I: intervention |
Questionnaire-based studies, i.e., administration of a questionnaire/survey to collect participants’ opinion/perception about COVID-19 vaccine hesitancy/acceptance. |
Studies about other topics and/or that were not questionnaire-based. |
C: comparison |
When applicable (e.g., studies carried out in more than one country). |
|
O: outcomes |
To estimate the predictors of vaccine acceptance or vaccine hesitancy through a multivariate regression model. |
Studies not estimating the predictors of vaccine acceptance or vaccine hesitancy through a multivariate regression model. |
S: study design |
Descriptive national studies, or descriptive studies enrolling at least 500 participants from the general population and carried out at a national level. |
Studies enrolling less than 500 participants from the general population. |